By mining our previously published scRNA-seq data, we showed that tumour local administration (both topical application and intratumoural injection) of caerin 1.1/1.9 significantly activated the IFN-α response pathway in different phenotypes of tumour macrophages, in general, similar to that exhibited by the tumour macrophages of early CC patients. Here, IFNA1 is linked to neoplasm.